Pharmaceutical Non-Active Ingredients TRIZ Cases

Segmented oligomeric peptides bind proteoglycans for targeted delivery, resolving the trade-off between in vivo stability and cellular specificity.

An emulsified food composition uses gum arabic and divalent metal salts to maintain fluidity during heat sterilization.

Anti-Trop-2 antibody-drug conjugates employ a protease-cleavable carbamate linker to stabilize SN-38 in serum while enabling targeted release at tumor sites.

Cleavable linkers degrade the sulfate shell of a dendritic polyglycerol derivative, reducing organ accumulation and improving biodistribution.

Conjugating Amphotericin B with facial amphiphiles reduces systemic toxicity while enabling therapeutic concentrations to reach the subarachnoid space.

A transdermal patch formulation uses ropivacaine with penetration enhancers to increase skin permeation rates.

Linking MOG peptides to mannan via Lys-Gly bridges stabilizes antigens and reduces side effects in autoimmune therapy.

Ionic silicone hydrogel polymers use controlled anionic components to enhance protein uptake while maintaining thermal stability.

Pharmaceutical composition combining antipsychotics with conjugated linoleic acid to modulate androgen production.

Amphiphilic block copolymers self-assemble into stable nanoparticles at body temperature, reducing injection volume and dosing frequency.

Nonfunctional silicone oil stabilizes adhesive plaster releasability.

Targeted quenching at the antigen binding site resolves undirected signal loss from random quencher distribution, improving assay sensitivity.

Amino acid polymer-platinum conjugates overcome systemic toxicity and drug resistance by concentrating anticancer agents within tumor cells.

P2X7 receptor inhibitors block ATP signaling to reduce immune rejection and delay diabetes onset.

Isosorbide plasticization resolves gelatin-free transparency and stability trade-offs while maintaining dip time productivity.

Interconnected pores enable rapid fluid absorption while composite materials maintain mechanical strength against swelling-induced weakness.

Reaction of polysaccharide salts with anhydrides in formamide eliminates costly aprotic solvents while inducing viscoelastic characteristics.

Segmented ligands on a polymer brush enable selective binding to target cells, reducing off-target interactions in crowded biological environments.

Anthocyanins form ionic bonds with nitrite ions to maintain concentration during heat sterilization.

A nanoemulsifying composition stabilizes vitamin delivery using specific emulsifiers and antioxidants.

Fluorescent dyes label extracellular vesicles through lipid bilayer association, enabling detection with conventional instrumentation.

Pre-activated polyethylene glycol chains grafted onto a polyamine backbone maintain high peptide loading while overcoming manufacturing precision limitations.

Segmented beta helical protein conjugates bypass endocytic degradation to deliver genetic material safely.

Cationic ring-opening polymerization of cyclic imino ether monomers produces uniform polyoxazoline chains with high molar mass and narrow dispersity.

Cyclodextrin-functionalized nanoparticles bind homoserine lactone molecules, resolving insufficient quenching compound concentrations in biofilm infections.

Replacing 1-methylpiperidine-2-carboxylic acid improves liver metabolism, reducing toxicity while maintaining anti-tumor potency.

A helical polymeric backbone links proteins and peptides to create stable synthetic antigen-presenting cells.

siRNA oligonucleotides degrade ApoC3 mRNA to lower triglyceride levels, addressing modest efficacy in current hypertriglyceridemia therapies.

Conjugating polyethylene glycol to recombinant hCG N-terminus enhances protein stability and bioactivity.

Mill-drying moist microcrystalline cellulose eliminates spray-drying dilution, reducing energy consumption while maintaining particle size control.

Azobenzene boronic ester crosslinks enable reversible hydrogel stiffness tuning via light exposure.

Grind cellulose ether with a cationic surfactant to prevent agglomeration, reducing product loss and dust explosion risks.

Ligand-functionalized RNA nanoparticles move therapeutic agents to tumors, reducing systemic toxicity.

Surfactant-stabilized oil-in-water nanoemulsions improve bioavailability and stability of essential oils for transdermal delivery.

Amphiphilic block copolymers undergo LCST transitions in high macromolecular environments, enabling targeted payload release and minimizing systemic toxicity.

Fatty acid conjugates extend nucleic acid half-life by binding to human serum albumin, resolving insufficient in vivo stability.

Chitosan-siRNA conjugates extend circulation time via releasable polyethylene oxide linkages, addressing short half-life limitations in RNAi therapies.

Fluorinated porous materials replace degrading polyurethane foams, maintaining structural integrity in chemically aggressive environments.

Optimized POEGMA side chains minimize anti-PEG antibody induction while maintaining therapeutic stability.

PEGylated Serp-1 proteins extend half-life and thermal stability, reducing side effects while maintaining immune modulation.

Ester bonds attach pharmaceutical compounds to polyester copolymers, resolving low loading yields and unsustained release profiles.

Saponifying methylester prodrugs within alkaline liposomes converts them to ionized glucuronides, preventing burst release and leakage.

A bone-targeting polypeptide conjugate directs therapeutic antibodies to skeletal sites using site-specific pClick chemistry.

Hyaluronic acid conjugates target tumor-associated macrophages, reducing systemic toxicity while enhancing therapeutic efficacy.

EndoS trims N-linked glycans to core GlcNAc, enabling efficient transglutaminase conjugation at Q295 while preserving glycan integrity.

Chemoenzymatic glycan conjugation enables site-specific attachment of exatecan payloads to antibodies targeting Trop-2-expressing cells.

Amorphous formulation with solubilizing agents improves bioavailability and stability for poorly water-soluble drugs.

Dendron-linked oligonucleotide conjugates prevent protein adhesion to improve biodistribution and therapeutic efficacy in tumors.